Английская Википедия:AVN-101

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders.[1][2][3] As of November 2013, it was in phase II clinical trials for these indications.[2][3][4]Шаблон:Needs update

See also

References

Шаблон:Reflist

External links

Шаблон:Antidementia Шаблон:Serotonin receptor modulators


Шаблон:Nervous-system-drug-stub